It's a drug designed by Hoffmann-La Roche which functions being a potent and selective detrimental allosteric modulator for team II on the metabotropic glutamate receptors (mGluR2/three), getting equipotent at mGluR2 and mGluR3 but without activity at other mGluR subtypes.Apr 5, 2019 #one Hey there guys, I am planning on venturing into the earth of